Skip to main content
Top
Published in: BMC Infectious Diseases 1/2010

Open Access 01-12-2010 | Research article

Decreased Streptococcus pneumoniae susceptibility to oral antibiotics among children in rural Vietnam: a community study

Authors: Nguyen Quynh Hoa, Nguyen V Trung, Mattias Larsson, Bo Eriksson, Ho D Phuc, Nguyen TK Chuc, Cecilia Stalsby Lundborg

Published in: BMC Infectious Diseases | Issue 1/2010

Login to get access

Abstract

Background

Streptococcus pneumoniae is the most significant bacterial cause of community-acquired pneumonia among children under five years worldwide. Updated resistance information of S. pneumoniae among children is essential to adjust the recommendations for empirical treatment of community-acquired pneumonia, which will have immense implications for local and global health. This study investigated the prevalence of antibiotic resistance in isolated strains of S. pneumoniae and relationship with antibiotic use and demographic factors of children under five in rural Vietnam in 2007.

Methods

In Bavi district, 847 children 6 to 60 months were selected from 847 households. The main child-caregivers in the households were interviewed weekly using structured questionnaires to collect information of daily illness symptoms and drug use for the selected child over a four-week period (from March through June 2007). In the 3rd week, the children were invited for a clinical examination and to collect nasopharyngeal samples for S. pneumoniae identification. Etest and disk diffusion were used to test antibiotic susceptibility.

Results

Of 818 participating children, 258 (32%) had ongoing respiratory infections, 421 (52%) carried S. pneumoniae, and 477 (58%) had used antibiotics within the previous three weeks. Of the 421 isolates, 95% were resistant to at least one antibiotic (401/421). Resistance to co-trimoxazole, tetracycline, phenoxymethylpenicillin, erythromycin and ciprofloxacin was 78%, 75%, 75%, 70% and 28%, respectively. Low resistance was noted for amoxicillin (4%), benzylpenicillin (4%), and cefotaxime (2%). The intermediate resistance to amoxicillin was 32%. Multidrug-resistance was seen in 60%. The most common pattern was co-resistance to co-trimoxazole, tetracycline and erythromycin. The proportion of children carrying resistant bacteria was higher among the children who had used antibiotics in the previous three weeks.

Conclusions

Resistance to commonly used antibiotics and multidrug-resistance of S. pneumoniae in the area is remarkably high. High-dose amoxicillin is the only investigated oral antibiotic that can possibly be used for treatment of community-acquired pneumococcal infections. Strategies to promote appropriate prescribing and dispensing of effective antibiotics should be immediately implemented for the benefit of local and global health.
Appendix
Available only for authorised users
Literature
1.
go back to reference Michelow IC, Olsen K, Lozano J, Rollins NK, Duffy LB, Ziegler T, Kauppila J, Leinonen M, McCracken GH: Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics. 2004, 113 (4): 701-707. 10.1542/peds.113.4.701.CrossRefPubMed Michelow IC, Olsen K, Lozano J, Rollins NK, Duffy LB, Ziegler T, Kauppila J, Leinonen M, McCracken GH: Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics. 2004, 113 (4): 701-707. 10.1542/peds.113.4.701.CrossRefPubMed
2.
go back to reference Murray PR, Rosenthal KS, Pfaller MA: Medical Microbiology. 2005, St. Louis: Elsevier Mosby Murray PR, Rosenthal KS, Pfaller MA: Medical Microbiology. 2005, St. Louis: Elsevier Mosby
3.
go back to reference Song JH, Jung SI, Ko KS, Kim NY, Son JS, Chang HH, Ki HK, Oh WS, Suh JY, Peck KR, et al: High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob Agents Chemother. 2004, 48 (6): 2101-2107. 10.1128/AAC.48.6.2101-2107.2004.CrossRefPubMedPubMedCentral Song JH, Jung SI, Ko KS, Kim NY, Son JS, Chang HH, Ki HK, Oh WS, Suh JY, Peck KR, et al: High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob Agents Chemother. 2004, 48 (6): 2101-2107. 10.1128/AAC.48.6.2101-2107.2004.CrossRefPubMedPubMedCentral
4.
go back to reference Adam D: Global antibiotic resistance in Streptococcus pneumoniae. J Antimicrob Chemother. 2002, 50 (Suppl): 1-5.CrossRefPubMed Adam D: Global antibiotic resistance in Streptococcus pneumoniae. J Antimicrob Chemother. 2002, 50 (Suppl): 1-5.CrossRefPubMed
5.
go back to reference Jacobs MR, Felmingham D, Appelbaum PC, Gruneberg RN: The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother. 2003, 52 (2): 229-246. 10.1093/jac/dkg321.CrossRefPubMed Jacobs MR, Felmingham D, Appelbaum PC, Gruneberg RN: The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother. 2003, 52 (2): 229-246. 10.1093/jac/dkg321.CrossRefPubMed
6.
go back to reference Riedel S, Beekmann SE, Heilmann KP, Richter SS, Garcia-de-Lomas J, Ferech M, Goosens H, Doern GV: Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis. 2007, 26 (7): 485-490. 10.1007/s10096-007-0321-5.CrossRefPubMed Riedel S, Beekmann SE, Heilmann KP, Richter SS, Garcia-de-Lomas J, Ferech M, Goosens H, Doern GV: Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis. 2007, 26 (7): 485-490. 10.1007/s10096-007-0321-5.CrossRefPubMed
7.
go back to reference Feikin DR, Schuchat A, Kolczak M, Barrett NL, Harrison LH, Lefkowitz L, McGeer A, Farley MM, Vugia DJ, Lexau C, et al: Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am J Public Health. 2000, 90 (2): 223-229. 10.2105/AJPH.90.2.223.CrossRefPubMedPubMedCentral Feikin DR, Schuchat A, Kolczak M, Barrett NL, Harrison LH, Lefkowitz L, McGeer A, Farley MM, Vugia DJ, Lexau C, et al: Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am J Public Health. 2000, 90 (2): 223-229. 10.2105/AJPH.90.2.223.CrossRefPubMedPubMedCentral
8.
go back to reference Tleyjeh IM, Tlaygeh HM, Hejal R, Montori VM, Baddour LM: The impact of penicillin resistance on short-term mortality in hospitalized adults with pneumococcal pneumonia: a systematic review and meta-analysis. Clin Infect Dis. 2006, 42 (6): 788-797. 10.1086/500140.CrossRefPubMed Tleyjeh IM, Tlaygeh HM, Hejal R, Montori VM, Baddour LM: The impact of penicillin resistance on short-term mortality in hospitalized adults with pneumococcal pneumonia: a systematic review and meta-analysis. Clin Infect Dis. 2006, 42 (6): 788-797. 10.1086/500140.CrossRefPubMed
9.
go back to reference Goossens H, Ferech M, Stichele RV, Elseviers M: Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005, 365 (9459): 579-587.CrossRefPubMed Goossens H, Ferech M, Stichele RV, Elseviers M: Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005, 365 (9459): 579-587.CrossRefPubMed
10.
go back to reference Larsson M, Kronvall G, Chuc NT, Karlsson I, Lager F, Hanh HD, Tomson G, Falkenberg T: Antibiotic medication and bacterial resistance to antibiotics: a survey of children in a Vietnamese community. Trop Med Int Health. 2000, 5 (10): 711-721. 10.1046/j.1365-3156.2000.00630.x.CrossRefPubMed Larsson M, Kronvall G, Chuc NT, Karlsson I, Lager F, Hanh HD, Tomson G, Falkenberg T: Antibiotic medication and bacterial resistance to antibiotics: a survey of children in a Vietnamese community. Trop Med Int Health. 2000, 5 (10): 711-721. 10.1046/j.1365-3156.2000.00630.x.CrossRefPubMed
11.
go back to reference Parry CM, Diep TS, Wain J, Hoa NT, Gainsborough M, Nga D, Davies C, Phu NH, Hien TT, White NJ, et al: Nasal carriage in Vietnamese children of Streptococcus pneumoniae resistant to multiple antimicrobial agents. Antimicrob Agents Chemother. 2000, 44 (3): 484-488. 10.1128/AAC.44.3.484-488.2000.CrossRefPubMedPubMedCentral Parry CM, Diep TS, Wain J, Hoa NT, Gainsborough M, Nga D, Davies C, Phu NH, Hien TT, White NJ, et al: Nasal carriage in Vietnamese children of Streptococcus pneumoniae resistant to multiple antimicrobial agents. Antimicrob Agents Chemother. 2000, 44 (3): 484-488. 10.1128/AAC.44.3.484-488.2000.CrossRefPubMedPubMedCentral
12.
go back to reference Hoa NQ, Ohman A, Lundborg CS, Chuc NT: Drug use and health-seeking behavior for childhood illness in Vietnam--a qualitative study. Health Policy. 2007, 82 (3): 320-329. 10.1016/j.healthpol.2006.10.005.CrossRefPubMed Hoa NQ, Ohman A, Lundborg CS, Chuc NT: Drug use and health-seeking behavior for childhood illness in Vietnam--a qualitative study. Health Policy. 2007, 82 (3): 320-329. 10.1016/j.healthpol.2006.10.005.CrossRefPubMed
13.
go back to reference Hoa NQ, Larson M, Kim Chuc NT, Eriksson B, Trung NV, Stalsby CL: Antibiotics and paediatric acute respiratory infections in rural Vietnam: health-care providers' knowledge, practical competence and reported practice. Trop Med Int Health. 2009, 14 (5): 546-555. 10.1111/j.1365-3156.2009.02267.x.CrossRefPubMed Hoa NQ, Larson M, Kim Chuc NT, Eriksson B, Trung NV, Stalsby CL: Antibiotics and paediatric acute respiratory infections in rural Vietnam: health-care providers' knowledge, practical competence and reported practice. Trop Med Int Health. 2009, 14 (5): 546-555. 10.1111/j.1365-3156.2009.02267.x.CrossRefPubMed
14.
go back to reference Chuc NT, Diwan V: FilaBavi, a demographic surveillance site, an epidemiological field laboratory in Vietnam. Scand J Public Health Suppl. 2003, 62: 3-7. 10.1080/14034950310015031.CrossRefPubMed Chuc NT, Diwan V: FilaBavi, a demographic surveillance site, an epidemiological field laboratory in Vietnam. Scand J Public Health Suppl. 2003, 62: 3-7. 10.1080/14034950310015031.CrossRefPubMed
15.
go back to reference WHO collaborating Centre for Drug Statistics Methodology: Anatomical Therapeutic Chemical (ATC) classification index with Defined Daily Doses (DDDs) 2009. 2008, Oslo: WHO WHO collaborating Centre for Drug Statistics Methodology: Anatomical Therapeutic Chemical (ATC) classification index with Defined Daily Doses (DDDs) 2009. 2008, Oslo: WHO
16.
go back to reference Hanoi University of Pharmacy: VN Pharmacy, the Vietnamese software for Anatomical Therapeutical Chemical Classification System with Defined Daily Dose (ATC/DDD). 2004, Hanoi: Hanoi University of Pharmacy Hanoi University of Pharmacy: VN Pharmacy, the Vietnamese software for Anatomical Therapeutical Chemical Classification System with Defined Daily Dose (ATC/DDD). 2004, Hanoi: Hanoi University of Pharmacy
17.
go back to reference Michelow IC, Lozano J, Olsen K, Goto C, Rollins NK, Ghaffar F, Rodriguez-Cerrato V, Leinonen M, McCracken GH: Diagnosis of Streptococcus pneumoniae lower respiratory infection in hospitalized children by culture, polymerase chain reaction, serological testing, and urinary antigen detection. Clin Infect Dis. 2002, 34 (1): E1-11. 10.1086/324358.CrossRefPubMed Michelow IC, Lozano J, Olsen K, Goto C, Rollins NK, Ghaffar F, Rodriguez-Cerrato V, Leinonen M, McCracken GH: Diagnosis of Streptococcus pneumoniae lower respiratory infection in hospitalized children by culture, polymerase chain reaction, serological testing, and urinary antigen detection. Clin Infect Dis. 2002, 34 (1): E1-11. 10.1086/324358.CrossRefPubMed
18.
go back to reference Clinical and Laboratory Standards Institute (CLSI): Performance Standards for Antimicrobial Susceptibility Testing; Nineteenth Informational Supplement. M100-S19. 2009, Wayne, USA, 29: Clinical and Laboratory Standards Institute (CLSI): Performance Standards for Antimicrobial Susceptibility Testing; Nineteenth Informational Supplement. M100-S19. 2009, Wayne, USA, 29:
21.
go back to reference Trinh OT, Nguyen ND, Dibley MJ, Phongsavan P, Bauman AE: The prevalence and correlates of physical inactivity among adults in Ho Chi Minh City. BMC Public Health. 2008, 8: 204-10.1186/1471-2458-8-204.CrossRefPubMedPubMedCentral Trinh OT, Nguyen ND, Dibley MJ, Phongsavan P, Bauman AE: The prevalence and correlates of physical inactivity among adults in Ho Chi Minh City. BMC Public Health. 2008, 8: 204-10.1186/1471-2458-8-204.CrossRefPubMedPubMedCentral
22.
go back to reference Nilsson P, Laurell MH: Carriage of penicillin-resistant Streptococcus pneumoniae by children in day-care centers during an intervention program in Malmo, Sweden. Pediatr Infect Dis J. 2001, 20 (12): 1144-1149. 10.1097/00006454-200112000-00010.CrossRefPubMed Nilsson P, Laurell MH: Carriage of penicillin-resistant Streptococcus pneumoniae by children in day-care centers during an intervention program in Malmo, Sweden. Pediatr Infect Dis J. 2001, 20 (12): 1144-1149. 10.1097/00006454-200112000-00010.CrossRefPubMed
23.
go back to reference Yu S, Yao K, Shen X, Zhang W, Liu X, Yang Y: Serogroup distribution and antimicrobial resistance of nasopharyngeal isolates of Streptococcus pneumoniae among Beijing children with upper respiratory infections (2000-2005). Eur J Clin Microbiol Infect Dis. 2008, 27 (8): 649-655. 10.1007/s10096-008-0481-y.CrossRefPubMed Yu S, Yao K, Shen X, Zhang W, Liu X, Yang Y: Serogroup distribution and antimicrobial resistance of nasopharyngeal isolates of Streptococcus pneumoniae among Beijing children with upper respiratory infections (2000-2005). Eur J Clin Microbiol Infect Dis. 2008, 27 (8): 649-655. 10.1007/s10096-008-0481-y.CrossRefPubMed
24.
go back to reference Marchisio P, Esposito S, Schito GC, Marchese A, Cavagna R, Principi N: Nasopharyngeal carriage of Streptococcus pneumoniae in healthy children: implications for the use of heptavalent pneumococcal conjugate vaccine. Emerg Infect Dis. 2002, 8 (5): 479-484.CrossRefPubMedPubMedCentral Marchisio P, Esposito S, Schito GC, Marchese A, Cavagna R, Principi N: Nasopharyngeal carriage of Streptococcus pneumoniae in healthy children: implications for the use of heptavalent pneumococcal conjugate vaccine. Emerg Infect Dis. 2002, 8 (5): 479-484.CrossRefPubMedPubMedCentral
25.
go back to reference Deeks SL, Palacio R, Ruvinsky R, Kertesz DA, Hortal M, Rossi A, Spika JS, Di Fabio JL: Risk factors and course of illness among children with invasive penicillin-resistant Streptococcus pneumoniae. The Streptococcus pneumoniae Working Group. Pediatrics. 1999, 103 (2): 409-413. 10.1542/peds.103.2.409.CrossRefPubMed Deeks SL, Palacio R, Ruvinsky R, Kertesz DA, Hortal M, Rossi A, Spika JS, Di Fabio JL: Risk factors and course of illness among children with invasive penicillin-resistant Streptococcus pneumoniae. The Streptococcus pneumoniae Working Group. Pediatrics. 1999, 103 (2): 409-413. 10.1542/peds.103.2.409.CrossRefPubMed
26.
go back to reference Henriques-Normark B, Blomberg C, Dagerhamn J, Battig P, Normark S: The rise and fall of bacterial clones: Streptococcus pneumoniae. Nat Rev Microbiol. 2008, 6 (11): 827-837. 10.1038/nrmicro2011.CrossRefPubMed Henriques-Normark B, Blomberg C, Dagerhamn J, Battig P, Normark S: The rise and fall of bacterial clones: Streptococcus pneumoniae. Nat Rev Microbiol. 2008, 6 (11): 827-837. 10.1038/nrmicro2011.CrossRefPubMed
27.
go back to reference Dinleyici EC, Yargic ZA: Pneumococcal conjugated vaccines: impact of PCV-7 and new achievements in the postvaccine era. Expert Rev Vaccines. 2008, 7 (9): 1367-1394. 10.1586/14760584.7.9.1367.CrossRefPubMed Dinleyici EC, Yargic ZA: Pneumococcal conjugated vaccines: impact of PCV-7 and new achievements in the postvaccine era. Expert Rev Vaccines. 2008, 7 (9): 1367-1394. 10.1586/14760584.7.9.1367.CrossRefPubMed
28.
go back to reference Bogaert D, Ha NT, Sluijter M, Lemmens N, De Groot R, Hermans PW: Molecular epidemiology of pneumococcal carriage among children with upper respiratory tract infections in Hanoi, Vietnam. J Clin Microbiol. 2002, 40 (11): 3903-3908. 10.1128/JCM.40.11.3903-3908.2002.CrossRefPubMedPubMedCentral Bogaert D, Ha NT, Sluijter M, Lemmens N, De Groot R, Hermans PW: Molecular epidemiology of pneumococcal carriage among children with upper respiratory tract infections in Hanoi, Vietnam. J Clin Microbiol. 2002, 40 (11): 3903-3908. 10.1128/JCM.40.11.3903-3908.2002.CrossRefPubMedPubMedCentral
29.
go back to reference Schultsz C, Vien le M, Campbell JI, Chau NV, Diep TS, Hoang NV, Nga TT, Savelkoul P, Stepnieuwska K, Parry C, et al: Changes in the nasal carriage of drug-resistant Streptococcus pneumoniae in urban and rural Vietnamese schoolchildren. Trans R Soc Trop Med Hyg. 2007, 101 (5): 484-492. 10.1016/j.trstmh.2006.08.010.CrossRefPubMed Schultsz C, Vien le M, Campbell JI, Chau NV, Diep TS, Hoang NV, Nga TT, Savelkoul P, Stepnieuwska K, Parry C, et al: Changes in the nasal carriage of drug-resistant Streptococcus pneumoniae in urban and rural Vietnamese schoolchildren. Trans R Soc Trop Med Hyg. 2007, 101 (5): 484-492. 10.1016/j.trstmh.2006.08.010.CrossRefPubMed
30.
go back to reference Reinert RR: Resistance phenotypes and multi-drug resistance in Streptococcus pneumoniae (PROTEKT years 1-3 [1999-2001]). J Chemother. 2004, 16 (Suppl 6): 35-48.PubMed Reinert RR: Resistance phenotypes and multi-drug resistance in Streptococcus pneumoniae (PROTEKT years 1-3 [1999-2001]). J Chemother. 2004, 16 (Suppl 6): 35-48.PubMed
31.
go back to reference Chen R, Chen Y, Black S, Hao CL, Ding YF, Zhang T, Zhao GM: Antibiotic Resistance Patterns and Serotype Distribution in Streptococcus pneumoniae from Hospitalized Pediatric Patients with Respiratory Infections in Suzhou, China. J Trop Pediatr. 2009. Chen R, Chen Y, Black S, Hao CL, Ding YF, Zhang T, Zhao GM: Antibiotic Resistance Patterns and Serotype Distribution in Streptococcus pneumoniae from Hospitalized Pediatric Patients with Respiratory Infections in Suzhou, China. J Trop Pediatr. 2009.
32.
go back to reference MOH: Handbook of integrated management for common childhood illness. 2006, Hanoi: Ministry of Health (MOH)- Vietnam MOH: Handbook of integrated management for common childhood illness. 2006, Hanoi: Ministry of Health (MOH)- Vietnam
33.
go back to reference Soriano F, Cafini F, Aguilar L, Tarrago D, Alou L, Gimenez MJ, Gracia M, Ponte MC, Leu D, Pana M, et al: Breakthrough in penicillin resistance? Streptococcus pneumoniae isolates with penicillin/cefotaxime MICs of 16 mg/L and their genotypic and geographical relatedness. J Antimicrob Chemother. 2008, 62 (6): 1234-1240. 10.1093/jac/dkn392.CrossRefPubMed Soriano F, Cafini F, Aguilar L, Tarrago D, Alou L, Gimenez MJ, Gracia M, Ponte MC, Leu D, Pana M, et al: Breakthrough in penicillin resistance? Streptococcus pneumoniae isolates with penicillin/cefotaxime MICs of 16 mg/L and their genotypic and geographical relatedness. J Antimicrob Chemother. 2008, 62 (6): 1234-1240. 10.1093/jac/dkn392.CrossRefPubMed
34.
go back to reference Hoan LT, Chuc NT, Ottosson E, Allebeck P: Drug use among children under 5 with respiratory illness and/or diarrhoea in a rural district of Vietnam. Pharmacoepidemiol Drug Saf. 2009, 18 (6): 448-453. 10.1002/pds.1730.CrossRef Hoan LT, Chuc NT, Ottosson E, Allebeck P: Drug use among children under 5 with respiratory illness and/or diarrhoea in a rural district of Vietnam. Pharmacoepidemiol Drug Saf. 2009, 18 (6): 448-453. 10.1002/pds.1730.CrossRef
35.
go back to reference McCormick AW, Whitney CG, Farley MM, Lynfield R, Harrison LH, Bennett NM, Schaffner W, Reingold A, Hadler J, Cieslak P, et al: Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States. Nat Med. 2003, 9 (4): 424-430. 10.1038/nm839.CrossRefPubMed McCormick AW, Whitney CG, Farley MM, Lynfield R, Harrison LH, Bennett NM, Schaffner W, Reingold A, Hadler J, Cieslak P, et al: Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States. Nat Med. 2003, 9 (4): 424-430. 10.1038/nm839.CrossRefPubMed
36.
go back to reference Tenover FC: Mechanisms of antimicrobial resistance in bacteria. Am J Med. 2006, 119 (6 Suppl 1): S3-10. 10.1016/j.amjmed.2006.03.011.CrossRefPubMed Tenover FC: Mechanisms of antimicrobial resistance in bacteria. Am J Med. 2006, 119 (6 Suppl 1): S3-10. 10.1016/j.amjmed.2006.03.011.CrossRefPubMed
37.
go back to reference Parry CM, Duong NM, Zhou J, Mai NT, Diep TS, Thinh le Q, Wain J, Van Vinh Chau N, Griffiths D, Day NP, et al: Emergence in Vietnam of Streptococcus pneumoniae resistant to multiple antimicrobial agents as a result of dissemination of the multiresistant Spain(23F)-1 clone. Antimicrob Agents Chemother. 2002, 46 (11): 3512-3517. 10.1128/AAC.46.11.3512-3517.2002.CrossRefPubMedPubMedCentral Parry CM, Duong NM, Zhou J, Mai NT, Diep TS, Thinh le Q, Wain J, Van Vinh Chau N, Griffiths D, Day NP, et al: Emergence in Vietnam of Streptococcus pneumoniae resistant to multiple antimicrobial agents as a result of dissemination of the multiresistant Spain(23F)-1 clone. Antimicrob Agents Chemother. 2002, 46 (11): 3512-3517. 10.1128/AAC.46.11.3512-3517.2002.CrossRefPubMedPubMedCentral
38.
go back to reference Linares J, Ardanuy C, Pallares R, Fenoll A: Changes in antimicrobial resistance, serotypes, and genotypes in Streptococcus pneumoniae over a thirty-year period. Clin Microbiol Infect. 2010. Linares J, Ardanuy C, Pallares R, Fenoll A: Changes in antimicrobial resistance, serotypes, and genotypes in Streptococcus pneumoniae over a thirty-year period. Clin Microbiol Infect. 2010.
39.
go back to reference Adam HJ, Hoban DJ, Gin AS, Zhanel GG: Association between fluoroquinolone usage and a dramatic rise in ciprofloxacin-resistant Streptococcus pneumoniae in Canada, 1997-2006. Int J Antimicrob Agents. 2009, 34 (1): 82-85. 10.1016/j.ijantimicag.2009.02.002.CrossRefPubMed Adam HJ, Hoban DJ, Gin AS, Zhanel GG: Association between fluoroquinolone usage and a dramatic rise in ciprofloxacin-resistant Streptococcus pneumoniae in Canada, 1997-2006. Int J Antimicrob Agents. 2009, 34 (1): 82-85. 10.1016/j.ijantimicag.2009.02.002.CrossRefPubMed
40.
go back to reference Vila-Corcoles A, Bejarano-Romero F, Salsench E, Ochoa-Gondar O, de Diego C, Gomez-Bertomeu F, Raga-Luria X, Cliville-Guasch X, Arija V: Drug-resistance in Streptococcus pneumoniae isolates among Spanish middle aged and older adults with community-acquired pneumonia. BMC Infect Dis. 2009, 9: 36-10.1186/1471-2334-9-36.CrossRefPubMedPubMedCentral Vila-Corcoles A, Bejarano-Romero F, Salsench E, Ochoa-Gondar O, de Diego C, Gomez-Bertomeu F, Raga-Luria X, Cliville-Guasch X, Arija V: Drug-resistance in Streptococcus pneumoniae isolates among Spanish middle aged and older adults with community-acquired pneumonia. BMC Infect Dis. 2009, 9: 36-10.1186/1471-2334-9-36.CrossRefPubMedPubMedCentral
41.
go back to reference Goossens H, Ferech M, Coenen S, Stephens P: Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries. Clin Infect Dis. 2007, 44 (8): 1091-1095. 10.1086/512810.CrossRefPubMed Goossens H, Ferech M, Coenen S, Stephens P: Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries. Clin Infect Dis. 2007, 44 (8): 1091-1095. 10.1086/512810.CrossRefPubMed
42.
go back to reference Grant GB, Campbell H, Dowell SF, Graham SM, Klugman KP, Mulholland EK, Steinhoff M, Weber MW, Qazi S: Recommendations for treatment of childhood non-severe pneumonia. Lancet Infect Dis. 2009, 9 (3): 185-196. 10.1016/S1473-3099(09)70044-1.CrossRefPubMed Grant GB, Campbell H, Dowell SF, Graham SM, Klugman KP, Mulholland EK, Steinhoff M, Weber MW, Qazi S: Recommendations for treatment of childhood non-severe pneumonia. Lancet Infect Dis. 2009, 9 (3): 185-196. 10.1016/S1473-3099(09)70044-1.CrossRefPubMed
43.
go back to reference Ginsburg CM, McCracken GH, Thomas ML, Clahsen J: Comparative pharmacokinetics of amoxicillin and ampicillin in infants and children. Pediatrics. 1979, 64 (5): 627-631.PubMed Ginsburg CM, McCracken GH, Thomas ML, Clahsen J: Comparative pharmacokinetics of amoxicillin and ampicillin in infants and children. Pediatrics. 1979, 64 (5): 627-631.PubMed
44.
go back to reference Sevillano D, Aguilar L, Alou L, Gimenez MJ, Gonzalez N, Echeverria O, Torrico M, Valdes L, Coronel P, Prieto J: Beta-lactam activity against penicillin-resistant Streptococcus pneumoniae strains exhibiting higher amoxicillin versus penicillin minimum inhibitory concentration values: an in vitro pharmacodynamic simulation. Chemotherapy. 2008, 54 (2): 84-90. 10.1159/000118659.CrossRefPubMed Sevillano D, Aguilar L, Alou L, Gimenez MJ, Gonzalez N, Echeverria O, Torrico M, Valdes L, Coronel P, Prieto J: Beta-lactam activity against penicillin-resistant Streptococcus pneumoniae strains exhibiting higher amoxicillin versus penicillin minimum inhibitory concentration values: an in vitro pharmacodynamic simulation. Chemotherapy. 2008, 54 (2): 84-90. 10.1159/000118659.CrossRefPubMed
45.
go back to reference Schurek KN, Adam HJ, Hoban DJ, Zhanel GG: Call for the international adoption of microbiological breakpoints for fluoroquinolones and Streptococcus pneumoniae. Int J Antimicrob Agents. 2006, 28 (3): 266-269. 10.1016/j.ijantimicag.2006.04.007.CrossRefPubMed Schurek KN, Adam HJ, Hoban DJ, Zhanel GG: Call for the international adoption of microbiological breakpoints for fluoroquinolones and Streptococcus pneumoniae. Int J Antimicrob Agents. 2006, 28 (3): 266-269. 10.1016/j.ijantimicag.2006.04.007.CrossRefPubMed
Metadata
Title
Decreased Streptococcus pneumoniae susceptibility to oral antibiotics among children in rural Vietnam: a community study
Authors
Nguyen Quynh Hoa
Nguyen V Trung
Mattias Larsson
Bo Eriksson
Ho D Phuc
Nguyen TK Chuc
Cecilia Stalsby Lundborg
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2010
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-10-85

Other articles of this Issue 1/2010

BMC Infectious Diseases 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine